• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognosis and staging of non-alcoholic fatty liver disease.

作者信息

Jepsen Peter, Grønbæk Henning

出版信息

BMJ. 2011 Nov 18;343:d7302. doi: 10.1136/bmj.d7302.

DOI:10.1136/bmj.d7302
PMID:22102440
Abstract
摘要

相似文献

1
Prognosis and staging of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的预后与分期
BMJ. 2011 Nov 18;343:d7302. doi: 10.1136/bmj.d7302.
2
[Fatty liver: frequent and not completely harmless].[脂肪肝：常见且并非完全无害]
Praxis (Bern 1994). 2013 Sep 4;102(18):1089-101. doi: 10.1024/1661-8157/a001420.
3
Prevalence and mortality prognosis of steatotic liver disease phenotypes.脂肪性肝病表型的患病率及死亡预后
Ann Hepatol. 2024 May-Jun;29(3):101487. doi: 10.1016/j.aohep.2024.101487. Epub 2024 Feb 23.
4
Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?在丙型肝炎病毒治疗效果更佳的时代，非酒精性脂肪性肝炎（NASH）患病率的上升会使NASH成为更致命的疾病吗？
Hepatology. 2011 Oct;54(4):1118-20. doi: 10.1002/hep.24634.
5
Reply to: Correspondence on "clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease'.回复：关于“代谢功能障碍相关脂肪性肝病和非酒精性脂肪性肝病的临床特征及死亡率相似”的通信
J Hepatol. 2024 Oct;81(4):e160-e161. doi: 10.1016/j.jhep.2024.05.024. Epub 2024 May 23.
6
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.脂肪肝患者的预后——一项基于登记处的队列研究。
Hepatogastroenterology. 2003 Nov-Dec;50(54):2101-4.
7
[NASH (non-alcoholic steatohepatitis): fatty liver or fatal liver disease?].[非酒精性脂肪性肝炎（NASH）：脂肪肝还是致命性肝病？]
Zentralbl Chir. 2014 Apr;139(2):168-74. doi: 10.1055/s-0031-1283813. Epub 2012 Mar 22.
8
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患儿非酒精性脂肪性肝炎的无创预测模型
Dig Liver Dis. 2014 Nov;46(11):1008-13. doi: 10.1016/j.dld.2014.07.016. Epub 2014 Aug 6.
9
Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.再刊：非酒精性脂肪性肝病：无创性检查与危险分层。
Postgrad Med J. 2014 May;90(1063):254-66. doi: 10.1136/postgradmedj-2013-201620rep.
10
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.在非酒精性脂肪性肝病患者中，代谢异常个体的死亡率更高，而代谢正常个体则没有。
Metabolism. 2013 Mar;62(3):352-60. doi: 10.1016/j.metabol.2012.08.005. Epub 2012 Sep 19.

引用本文的文献

1
Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis.血浆脂肪酸组成与非酒精性脂肪性肝炎的组织学表现相关。
Biomedicines. 2022 Oct 12;10(10):2540. doi: 10.3390/biomedicines10102540.
2
Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.芳香酶抑制剂与绝经后早期乳腺癌患者新发非酒精性脂肪性肝病：一项倾向评分匹配队列研究。
Oncologist. 2019 Aug;24(8):e653-e661. doi: 10.1634/theoncologist.2018-0370. Epub 2019 Jan 24.
3
Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data.
退伍军人管理局人群中的非酒精性脂肪性肝病（NAFLD）：使用自动化数据开发和验证NAFLD算法
Aliment Pharmacol Ther. 2014 Oct;40(8):949-54. doi: 10.1111/apt.12923. Epub 2014 Aug 26.
4
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study.血清氧化应激标志物和脂质组学特征用于检测对抗氧化治疗有反应的非酒精性脂肪性肝炎患者：一项初步研究。
Oxid Med Cell Longev. 2014;2014:169216. doi: 10.1155/2014/169216. Epub 2014 Jun 2.